Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
about
Regulators of autophagosome formation in Drosophila musclesRole of autophagy in glycogen breakdown and its relevance to chloroquine myopathyIdentification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.Interferon-alpha: a therapeutic target in systemic lupus erythematosusMethodological issues of corticosteroid use in SLE clinical trials.Therapy of systemic lupus erythematosus: new agents and new evidence.Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.Lupus nephritis: a review of the current pharmacological treatments.Kozhikode criteria for diagnosing systemic lupus erythematosus as a hematological disorder.Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patientsChloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis.Developments in the clinical understanding of lupusThe role of antimalarial agents in the treatment of SLE and lupus nephritis.Existing drugs and their application in drug discovery targeting cancer stem cells.Clinical and serological features distinguish patients with incomplete lupus classification from systemic lupus erythematosus patients and controls.Protective effect of quercetin on chloroquine-induced oxidative stress and hepatotoxicity in mice.Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.Factors associated with chloroquine-induced retinopathy in rheumatic diseases.Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark.A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan.Hydroxychloroquine: the cornerstone of lupus therapy.Characterisation of Patients with Systemic Lupus Erythematosus in Malta: A Population Based Cohort Cross-Sectional Study
P2860
Q27311465-D3E2A0C8-1F9C-4394-BA5E-2F86A662F1D9Q27316640-CA98CEB2-D067-462F-A5AB-351637BF45B3Q30540705-D351D272-20D8-40CF-9530-DE5A0C7FF7A5Q33744320-F4B3AC47-B40F-489B-B788-D82B777D4B23Q33777440-A38EFA1F-144C-4D0F-9CCA-EAFDFC2343EDQ34074960-4FC11E8F-DA43-48CE-9C50-D35509B8BA0CQ34604474-F0B726F9-A036-427F-A30B-73A961D8DC5EQ35925513-B2D465F3-0FB5-47DC-B004-CA9C1FB5029DQ36688076-E545EF09-87E9-42CC-95EB-C375994B1D2DQ36844843-E6E182FE-F53B-4C0F-8353-E57C885E9709Q36906782-5BB4FBDF-5700-4E0F-9055-C69D6E24CC68Q37018076-D2A2F075-97C9-4EAC-B719-711615A1D148Q37453947-0CC6092A-E3F1-448D-8EC6-9E0075B8A619Q37947108-D2365E1E-EF34-4137-9A48-845AB6051D98Q38543730-ACFEC14C-2F1B-49CD-95B7-FD36A51999A3Q38766335-34FBE08B-C670-46D8-9E0D-1EF2956476A8Q39826465-B778E31E-85FE-4B78-9941-3F0F66DD2657Q41913969-665BA31A-F45C-4A94-9673-07E8AE7AC3D7Q41914430-67327135-BF52-4713-8DAF-514A7EC5095DQ41919852-EF14D7DE-D8A9-4993-8F0F-87FA0D33C040Q41926859-620F4E35-0878-4A9E-9D79-CB3B60F97EFBQ41943173-A2DED9C5-36A5-40E0-816F-733863B788AFQ43417859-5BB08B11-ED00-48E9-914D-621B499EA607Q45362554-B9C3CC3C-665D-49A0-AE59-EB76C9EF1676Q46643929-D9AB2143-3D1D-466D-A32D-FE34178E5580Q58603726-87C3F5E9-021D-4271-8C2E-DF00C59F09A3
P2860
Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
@en
type
label
Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
@en
prefLabel
Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
@en
P2093
P2860
P1433
P1476
Controlled trial with chloroquine diphosphate in systemic lupus erythematosus
@en
P2093
P2860
P304
P356
10.1177/096120339600500313
P577
1996-06-01T00:00:00Z